MXPA04007186A - Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion. - Google Patents

Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion.

Info

Publication number
MXPA04007186A
MXPA04007186A MXPA04007186A MXPA04007186A MXPA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A MX PA04007186 A MXPA04007186 A MX PA04007186A
Authority
MX
Mexico
Prior art keywords
radical
same
medicaments
producing
pharmaceutical compositions
Prior art date
Application number
MXPA04007186A
Other languages
English (en)
Inventor
Mauger Jacques
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MXPA04007186A publication Critical patent/MXPA04007186A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invencion se refiere a los productos de formula (I), en la que R1 representa un atomo de hidrogeno o un radical alquilo, COR, COOR, arilo o aralquilo opcionalmente sustituido; R2 represente un radical de formula (II), en la que n es igual a o, 1, 2 o 3, y X puede ser un radical saturado o insaturado, monociclito, biciclico, heterociclo, un radical arilo, un radical NR4R5 o un radical COR; y R3 es un radical de formula -Y- (CH2)m-C(CN)R6R7, en la que Y en un atomo de oxigeno o un grupo-N(R8)-, m vale 0, 1, 2 o 3.Estos productos se destinan a la prevencion o tratamiento de enfermedades en la que estan implicadas enzimas metabolicas elegidas entre proteasas y quinasas.
MXPA04007186A 2002-02-11 2003-02-07 Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion. MXPA04007186A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0201632A FR2835835B1 (fr) 2002-02-11 2002-02-11 Nouveaux derives de la pyridazine, leur utilisation comme medicaments, compositions pharmaceutiques et leur procede de preparation
PCT/FR2003/000381 WO2003068140A2 (fr) 2002-02-11 2003-02-07 Derives de la pyridazine, leur utilisation comme medicaments, et leur procede de preparation

Publications (1)

Publication Number Publication Date
MXPA04007186A true MXPA04007186A (es) 2004-10-29

Family

ID=27620073

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04007186A MXPA04007186A (es) 2002-02-11 2003-02-07 Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion.

Country Status (15)

Country Link
US (1) US7223758B2 (es)
EP (1) EP1476434B1 (es)
JP (1) JP4447324B2 (es)
AT (1) ATE329907T1 (es)
AU (1) AU2003222363A1 (es)
BR (1) BR0307565A (es)
CA (1) CA2475439A1 (es)
CY (1) CY1107483T1 (es)
DE (1) DE60306122T2 (es)
DK (1) DK1476434T3 (es)
ES (1) ES2266806T3 (es)
FR (1) FR2835835B1 (es)
MX (1) MXPA04007186A (es)
PT (1) PT1476434E (es)
WO (1) WO2003068140A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839309B1 (fr) * 2002-05-03 2004-07-23 Aventis Pharma Sa Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation
WO2006091592A1 (en) * 2005-02-23 2006-08-31 Smithkline Beecham Corporation Naphthalene derivatives as modulators of the glucocorticoid receptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661058B2 (en) 1991-11-08 1995-07-13 Sankyo Company Limited Piperazic acid derivatives as collagenase inhibitor

Also Published As

Publication number Publication date
US20050165017A1 (en) 2005-07-28
JP4447324B2 (ja) 2010-04-07
WO2003068140A2 (fr) 2003-08-21
BR0307565A (pt) 2004-12-21
DE60306122D1 (de) 2006-07-27
JP2005525334A (ja) 2005-08-25
ATE329907T1 (de) 2006-07-15
EP1476434A2 (fr) 2004-11-17
EP1476434B1 (fr) 2006-06-14
ES2266806T3 (es) 2007-03-01
FR2835835B1 (fr) 2004-04-16
US7223758B2 (en) 2007-05-29
FR2835835A1 (fr) 2003-08-15
CA2475439A1 (fr) 2003-08-21
DK1476434T3 (da) 2006-10-16
PT1476434E (pt) 2006-10-31
WO2003068140A3 (fr) 2004-04-08
AU2003222363A1 (en) 2003-09-04
DE60306122T2 (de) 2007-06-06
CY1107483T1 (el) 2013-03-13

Similar Documents

Publication Publication Date Title
HUP0402376A2 (hu) Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények
UA39166C2 (uk) Похідні n-гідроксисечовини, що є інгібіторами ліпоксигенази у ссавців, спосіб їх одержання і спосіб інгібування ліпоксигенази у ссавців
NZ536734A (en) Spiroindolinepiperidine derivatives
IL166412A0 (en) Novel use of benzothiazole derivatives
MXPA05001581A (es) Algunas imidazopiridinas novedosas y su uso.
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
HUT55401A (en) Process for producing platinum(ii) complexes and pharmaceutical compositions comprising such compounds as active ingredient
RS101304A (sr) Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi
DE3767839D1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
HK1010881A1 (en) Derivatives of azetidine and pyrrolidine
UA48937C2 (uk) Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
NO20060383L (no) Substituerte diketopiperaziner og deres anvendelse som oksytocinantagonister
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
SI1483251T1 (sl) C cian epotilonski derivati
CA2321188A1 (en) Derivatives of azetidine and pyrrolidine
MY133527A (en) Isoquinoline derivatives
PE20040750A1 (es) Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3
NZ524742A (en) Bridged piperazine derivatives
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
ATE239711T1 (de) Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
MXPA04007186A (es) Nuevos derivados de la piridazina, su utilizacion como medicamentos, composiciones farmaceuticas y su procedimiento de preparacion.
ES2148561T3 (es) Prevencion y curacion de enfermedades alergicas de tipo i.
MXPA05013225A (es) Derivados de 1-aril-4-(ariloxicarbonil)-piperazina para uso como inhibidores de la lipasa sensible a hormonas.
MXPA06004307A (es) Derivados de benzazepina como inhibidores de mao-b.